Synta Pharmaceuticals, Inc. (SNTA) Tops Q2 EPS by 3c

August 6, 2014 7:09 AM EDT

Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q2 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings